Cell Therapy Clinical Trials
2.6K posts
Cell Therapy Clinical Trials
@celltrialsdata
Weekly News of Cell and Gene Therapy (https://t.co/mFMH1rFvMb) Cell-based Therapy Clinical Trial Databases at (https://t.co/koODizmnHD)
London, England Katılım Mart 2017
97 Takip Edilen1.5K Takipçiler
Cell Therapy Clinical Trials retweetledi
I launched a Skool community.
Teaching you how to go from $0-$10K/month selling templates.
It’s going to cost $100/month in the future.
But for the next 48 hours only, it’s FREE to join.
To gain access, simply:
1. Like & Retweet
2. Reply "SKOOL"
3. Follow me (to receive DM)
English
You have no idea what digital products to sell?🤣🫵
What if I told you a full list of the 50 most profitable digital products for 2024 exist?
No outdated saturated products. Imagine the amount of sales you'd generate from it
Comment “P” & I’ll DM you the link to the full list.
English
If you have a PhD, you can make $100,000 online.
Want to know how?
Reply with "how" and I will share with you a step-by-step process.
English
English
A small @UCLBiochemEng1 contribution to Tumor spheroid formation for drug testing!
A huge congrats to @bioengineerx to drive this to the limits 😜
Ismail Eş@bioengineerx
aiche.onlinelibrary.wiley.com/doi/full/10.10… Check out the recent publication on optimized tumor spheroid formation for drug testing assisted with Monte Carlo simulation published @ChEnected. @MarcoPCMarques
English
English
Why I love this club. Pure emotion #LFC.
Liverpool Disabled Supporters Association@LiverpoolDSA
This is what it's all about giving young disabled supporters the opportunity to live their dreams and visit Anfield to watch their @LFC heroes. Impossible is nothing but only for those who truly believe. ❤️💚 Daire YNWA
English
Prompt engineers make $120k-$250k yearly.
So, I have prepared the "1000+ Advanced ChatGPT-4 Prompts" for you
You will get:
• 19+ chapters
• 1000+ Advanced ChatGPT-4 Prompts
And for 24 hours only, it's FREE!
To get it,
• Like
• Reply "pro"
• Follow me (so that I can DM)
English
I am thrilled to announce that my latest research article has been published: This study demonstrates for the first time that hMSCs transduced with lentiviral vectors can be successfully expanded in agitated conditions using microcarriers.
#article-info" target="_blank" rel="nofollow noopener">link.springer.com/article/10.100…
English
Cell Therapy Clinical Trials retweetledi
Cell Therapy Clinical Trials retweetledi
Ever wondered what happened to #celltherapies for #COVID19???
🤔🤔🤔
Check out this comprehensive study initiated by Fran & Pedro
👏👏👏
@celltrialsdata @ISCTglobal @AgenciaFAPESP @ChariteBerlin @berlinnovation @Yale @ucl @MesenchymalCell #SARSCoV2
👇👇👇
frontiersin.org/articles/10.33…
English
@CaicedoLab @ISCT_ESP @PatriciaRocco15 @MaroonKhoury @TatiMaron @LeonMorenoLC @katyramirezgg @USFQ_Ecuador @CristinaRuizMed @sebastianjpc1 @MantillaGonzalo @vincdicerbo @USFQ_COCIBA @DragonBioMed @DatoCienciaEC @KunaEcuador @CGTCatapult Legenddd @CaicedoLab it was a pleasure to meet you in person!
English
Thank you @PatriciaRocco15, @MaroonKhoury, Antonio Campos, Milena Soares, Hector Mayani, @TatiMaron, @LeonMorenoLC, @katyramirezgg, our @ISCT_ESP, @USFQ_Ecuador, @CristinaRuizMed, @sebastianjpc1, @MantillaGonzalo, my Lab Team for your unwavering support and the cherished moments!
English
I had an extraordinary moment at the @ISCTglobal meeting, receiving the Trailblazer award and the honor of being elected as Regional VP.
With an exceptional leadership team, we're ready to drive the field forward and uplift our @ISCT_ESP careers.
Heartfelt thanks to all involved!
English
(9/9) Non-Viral CAR-T Clinical Trial - Virus-free CAR-T cell product (PD1-19bbz) was evaluated in a clinical trial for adults with relapsed/refractory B-cell non-Hodgkin's lymphoma (B-NHL) showing CR= 86%, PFS of 19.5 months.
ncbi.nlm.nih.gov/pmc/articles/P…
English
What happened in the Cell and Gene Therapy sector last week! (Thread) (1/9)
cgtnewsletter.substack.com/p/22-cell-and-…
English
(8/9) CAR-T Cost Analysis Evaluation - Study focused on evaluating the cost-effectiveness of CAR-T treatments as a second line of treatment for diffuse large B-cell lymphoma shows that it's a cost-effective option in the US but not in China.
ncbi.nlm.nih.gov/pmc/articles/P…
English
(7/9) Next Generation CAR Products - Study focused on designing a next-generation CAR-NK product to target triple-negative breast cancer (TNBC), demonstrated cytotoxicity in vitro using a 3D tumor model.
ncbi.nlm.nih.gov/pmc/articles/P…
English
(6/9) Bristol Myers Squibb (BMS) is expanding its manufacturing capabilities by taking over a Novartis plant in Libertyville, Illinois.
fiercepharma.com/manufacturing/…
English
(5/9) Janssen Biotech to pay $245M to Cellular Biomedicine Group (CBMG) to develop next-generation CAR-T therapies for diffuse large B-cell lymphoma (DLBCL).
biospace.com/article/j-and-…
English
(4/9) Ossium Health secures $3.46M funding from California Institute for Regenerative Medicine (CIRM) to accelerate the development of OSSM-007, a promising treatment for steroid-refractory acute graft versus host disease (GvHD).
businesswire.com/news/home/2023…
English
(3/9) NanoFCM Co., Ltd, and RoosterBio to initiate a partnership to advance workflows in extracellular vesicle analytics.
prweb.com/releases/nanof…
English
(2/9) Direct Biologics receives FDA clearance for a clinical trial of ExoFlo™ in perianal fistulizing Crohn’s disease (news here). ExoFlo™ is an extracellular vesicle (EV) product using BM-hMSCs as a producer cell line (BM-hMSCs).
businesswire.com/news/home/2023…
English